LUMETTI, Federica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.843
AS - Asia 5.065
EU - Europa 3.724
SA - Sud America 707
Continente sconosciuto - Info sul continente non disponibili 185
AF - Africa 119
OC - Oceania 16
Totale 17.659
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.597
SG - Singapore 1.482
CN - Cina 1.268
IT - Italia 1.195
GB - Regno Unito 781
BR - Brasile 538
HK - Hong Kong 526
VN - Vietnam 502
BD - Bangladesh 367
SE - Svezia 360
DE - Germania 283
FI - Finlandia 229
FR - Francia 195
KR - Corea 182
IN - India 177
RU - Federazione Russa 171
CA - Canada 133
TR - Turchia 120
ID - Indonesia 117
UA - Ucraina 96
MX - Messico 67
JP - Giappone 61
NL - Olanda 60
AR - Argentina 58
BG - Bulgaria 55
ES - Italia 52
PL - Polonia 47
IQ - Iraq 37
ZA - Sudafrica 37
AT - Austria 33
PK - Pakistan 31
IE - Irlanda 30
MY - Malesia 25
PE - Perù 22
MA - Marocco 21
CO - Colombia 20
BE - Belgio 18
CL - Cile 18
CZ - Repubblica Ceca 17
IR - Iran 17
AE - Emirati Arabi Uniti 16
EC - Ecuador 16
NO - Norvegia 16
RO - Romania 16
SA - Arabia Saudita 15
AU - Australia 14
LT - Lituania 13
TW - Taiwan 13
VE - Venezuela 13
PY - Paraguay 12
TN - Tunisia 12
UZ - Uzbekistan 11
EG - Egitto 10
CH - Svizzera 9
CR - Costa Rica 9
KE - Kenya 9
NP - Nepal 9
AZ - Azerbaigian 8
JO - Giordania 8
GR - Grecia 7
HN - Honduras 7
IL - Israele 7
PH - Filippine 7
TH - Thailandia 7
AL - Albania 6
BH - Bahrain 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
HU - Ungheria 6
KZ - Kazakistan 6
BZ - Belize 5
PT - Portogallo 5
SY - Repubblica araba siriana 5
AO - Angola 4
BB - Barbados 4
BO - Bolivia 4
BY - Bielorussia 4
CY - Cipro 4
DK - Danimarca 4
DZ - Algeria 4
EU - Europa 4
GE - Georgia 4
KG - Kirghizistan 4
KH - Cambogia 4
RS - Serbia 4
AM - Armenia 3
JM - Giamaica 3
LB - Libano 3
NG - Nigeria 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
GT - Guatemala 2
HR - Croazia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
Totale 17.447
Salva come PNG Salva come JPEG
Città #
Santa Clara 989
Singapore 935
Ashburn 836
San Jose 539
Hong Kong 519
Fairfield 446
Southend 415
Chandler 414
Hefei 407
Council Bluffs 253
Woodbridge 251
London 199
Houston 195
Beijing 190
Nyköping 190
Ann Arbor 180
Seoul 170
New York 169
Helsinki 166
Seattle 164
Los Angeles 163
Wilmington 152
Jacksonville 150
Hanoi 146
Ho Chi Minh City 142
Cambridge 135
The Dalles 129
Modena 121
Dearborn 109
Milan 107
Chicago 94
San Diego 90
Jakarta 89
Bologna 82
Lauterbourg 73
Buffalo 65
Princeton 59
Shanghai 57
Izmir 54
Sofia 54
Rome 53
São Paulo 52
Parma 49
Atlanta 48
Moscow 48
Munich 45
Dallas 44
Frankfurt am Main 44
Orem 40
Bremen 39
Tokyo 39
Warsaw 37
Naples 36
Salt Lake City 34
Montreal 32
Toronto 32
Florence 29
Boardman 28
Denver 28
Lappeenranta 28
Delhi 27
Eugene 25
Chennai 24
Turin 24
Guangzhou 23
Kent 23
Paris 23
Stockholm 23
Da Nang 22
Haiphong 22
New Delhi 22
Valencia 22
Amsterdam 21
Columbus 21
Johannesburg 21
Reggio Emilia 21
Dublin 20
Mumbai 20
Redondo Beach 20
Mexico City 19
Redwood City 19
Ottawa 17
Charlotte 16
Lima 16
Phoenix 16
Rio de Janeiro 16
Turku 16
Brooklyn 15
Brussels 15
Manchester 15
San Francisco 15
Vancouver 15
Baghdad 13
Ovada 13
Poplar 13
Querétaro 13
Ankara 12
Boston 12
Elk Grove Village 12
Hillsboro 12
Totale 11.217
Salva come PNG Salva come JPEG
Nome #
Systemic sclerosis progression INvestiGation (SPRING) Italian registry: Demographic and clinico-serological features of the scleroderma spectrum 426
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature 373
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 347
Cardiac involvement in systemic sclerosis: identification of high-risk patient profiles in different patterns of clinical presentation 343
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 336
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 325
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 310
Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 308
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 303
APPLICATION OF CRITERIA FOR THE DIAGNOSIS OF “CLINICAL OSTEOPOROSIS ” IN A POPULATION OF POSTMENOPAUSAL WOMEN FROM EMILIA-ROMAGNA REGION 300
Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal 282
Diagnosis and treatment of rheumatoid arthritis in the Emilia Romagna region: a prospective population-based study 279
COMPLEMENT DEPLETION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOCILIZUMAB: A MARKER OF CLINICAL EFFICACY? 272
Beyond cat scratch disease: a case report of bartonella infection mimicking vasculitic disorder 271
Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution 269
Use of Neem oil and Hypericum perforatum for treatment of calcinosis-related skin ulcers in systemic sclerosis 261
Photobiomodulation Therapy: A New Light in the Treatment of Systemic Sclerosis Skin Ulcers 258
Autologous Fat Grafting for the Oral and Digital Complications of Systemic Sclerosis: Results of a Prospective Study 257
Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature 255
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 255
Adalimumab and ABP 501 in the Treatment of a Large Cohort of Patients with Inflammatory Arthritis: A Real Life Retrospective Analysis 253
Assessing hand grasp in patients with systemic sclerosis using the 16-grasp test: Preliminary results from a multidisciplinary study group 250
RETENTION RATE OF ADALIMUMAB AND ABP 501 IN THE TREATMENT OF A LARGE COHORT OF PATIENTS WITH INFLAMMATORY ARTHRITIS: A REAL LIFE RETROSPECTIVE ANALYSIS 246
A SELF-ADMINISTERED QUESTIONNAIRE MAY ALLOW GENERAL PRACTITIONERS TO PERFORM A RAPID SCREENING TO IDENTIFY PATIENTS AT RISK FOR FRAGILITY FRACTURES AND TO ADDRESS THEM TO BONE METABOLISM SPECIALIZED CLINICAL CENTERS 244
Osteomyelitis complicating scleroderma digital ulcers. 243
Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature 238
AB0611 STRAIN ANALYSIS OF THE RIGHT VENTRICLE USING 2D-SPECKLE TRACKING ECHOCARDIOGRAPHY IN A COHORT OF PATIENTS WITH SYSTEMIC SCLEROSIS 230
Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT study 228
Thu0349 autologous fat grafting in the treatment of patients with systemic sclerosis: current experience and future prospects 222
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 221
SEVERE VITAMIN D DEFICIENCY IN SYSTEMIC SCLEROSIS 220
Invited Response on: Comments on "Autologous Fat Grafting for the Oral and Digital Complications of Systemic Sclerosis: Results of a Prospective Study" 220
Baseline Ultrasound Assessment Improves the Response to Apremilast in Patients with Psoriatic Arthritis: Results from a Multicentre Study 219
DIGITAL NECROSIS IN SYSTEMIC SCLEROSIS NOT ONLY A MICROVASCULAR DISEASE: A CASE REPORT 215
Predictors of DAPSA Response in Psoriatic Arthritis Patients Treated with Apremilast in a Retrospective Observational Multi-Centric Study (2023-02-07) 211
Promising use of filgotinib in patients affected by systemic sclerosis: Preliminary data from a case series of 5 patients 209
AB0645 CANNABINOIDS IN THE TREATMENT OF PAIN RELATED TO SYSTEMIC SCLEROSIS SKIN ULCERS: OUR EXPERIENCE 208
The predictive role of the TAPSE/sPAP ratio for cardiovascular events and mortality in systemic sclerosis with pulmonary hypertension 207
AB0724 Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 207
Altered pathways of keratinization, extracellular matrix generation, angiogenesis, and stromal stem cells proliferation in patients with systemic sclerosis 204
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 204
One-year clinical experience on the use of Nintedanib in Systemic Sclerosis 202
AB0760 Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution 201
Molecular Pathways of Breast Cancer in Systemic Sclerosis: Exploratory Immunohistochemical Analysis from the Sclero-Breast Study 200
Predictive Value of DLCO Reduction in Scleroderma Patients Without Cardio-Pulmonary Involvement at Baseline 199
Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosis 199
Treatment with Rituximab in Systemic Sclerosis Patients: Our Experience in a Pilot Clinical Trial 189
Efficacy and Drug Survival after Switching from Etanercept to the Biosimilar SB4: A Real-Life Long-Term Study 188
AB0212 LONG-TERM TREATMENT WITH RITUXIMAB IN SYSTEMIC SCLEROSISMANAGEMENT: AN OVERVIEW OF THE CLINICAL EXPERIENCE FROM A REAL-LIFE SETTING 185
From Localized Scleroderma to Systemic Sclerosis: Coexistence or Possible Evolution 180
EFFICACY OF CERTOLIZUMAB PEGOL FOR DISEASE CONTROL OF PATIENTS AFFECTED BY ENTEROPATHIC SPONDYLARTHRITIS FOLLOWED BY THE JOINT GASTRO-RHEUMATOLOGICAL CLINIC 178
THU0600 a case of systemic sclerosis complicated by renal crisis: potential etiopathogenetic role of cytomegalovirus and treatment 178
A New Promising Role for Selexipag in the Treatment of Scleroderma Vasculopathy: Preliminary Results From a Third Level Italian Scleroderma Center 175
A CALL FOR A COMPREHENSIVE ROLE DEFINITION OF THE STUDY COORDINATOR IN RHEUMATOLOGICAL CLINICAL STUDIES 174
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 171
ACCERTAMENTO DELLA DISABILITÀ NELLE MALATTIE REUMATOLOGICHE (EX L.R. N.4 DEL 19 FEBBRAIO 2008) PROPOSTA DI PROTOCOLLO ORGANIZZATIVO 164
Long-term treatment of scleroderma-related digital ulcers with iloprost: a cohort study 162
PROBABILITÀ DI SIEROCONVERSIONE DEL TEST QUANTIFERON DURANTE LA TERAPIA BIOTECNOLOGICA: DATI PRELIMINARI DI UNO STUDIO RETROSPETTIVO CONDOTTO PRESSO L’ARTHRITIS CLINIC DELL’AZIENDA OSPEDALIERO-UNIVERSITARIA POLICLINICO DI MODENA 159
PSYCHIATRIC DISORDERS IN RHEUMATOLOGY: EVALUATION OF A SCREENING PROTOCOL IN 100 HOSPITALIZED PATIENTS 159
KIENBOCK DISEASE IN A PATIENT WITH SSc: A CASE REPORT 158
CYCLING VS SWAP TNFi AND IL17i IN PSORIATIC ARTHRITIS: RESULTS FROM THE BIRRA RETROSPECTIVE OBSERVATIONAL STUDY 157
SAT0285 EVALUATION OF CHRONIC PAIN IN PATIENTS WITH SYSTEMIC SCLEROSIS COMPARED TO THOSE WITH CHRONIC HEADACHE AND RHEUMATOID ARTHRITIS 155
Real life use of prostacyclin analog (Iloprost), a multi-centric survey data from the scleroderma study group Emilia Romagna (Sclero-RER) and review of the literature 149
CONFRONTO TRA STRATEGIE DI TERAPIA AVANZATA DI 2° E 3° LINEA NELLA ARTRITE PSORIASICA: RISULTATI PRELIMINARI DALLO STUDIO OSSERVAZIONE RETROSPETTIVO BIRRA 145
Cycling versus swapping strategieswith TNF-α inhibitors and IL-17 inhibitors in psoriatic arthritis in clinical practice 145
POS0604 JAKi’S SURVIVAL RATE AND PREDICTORS OF DISCONTINUATION IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS 144
FRI0442 Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 143
Erratum: From Localized Scleroderma to Systemic Sclerosis: Coexistence or Possible Evolution (Dermatology Research and Practice (2018) 2018 (1284687) DOI: 10.1155/2018/1284687) 139
MYCOPHENOLATE MOFETIL TREATMENT REDUCES THE RISK OF TREATMENT ESCALATION DUE TO VASCULAR COMPLICATIONS IN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS: EMULATION OF A TARGET TRIAL FROM ITALIAN RHEUMATOLOGY SOCIETY SPRING REGISTRY 133
DIFFERENCES BETWEEN SELECTIVE AND UNSELECTIVE JAKi: RESULTS FROM A MULTICENTRIC, REAL LIFE STUDY CARRIED OUT ON PATIENTS WITH RA 133
L’IPERTENSIONE POLMONARE: DALLE NUOVE LINEE GUIDA ALLA PRATICA CLINICA 129
Infections of scleroderma digital ulcers: A single center cohort retrospective study 123
Influence of safety warnings on the prescribing attitude of JAK 2inhibitors for rheumatoid arthritis in Italy 120
Effectiveness and Predictors of Long-Term Treatment Response to Tofacitinib in Rheumatoid Arthritis Cohort: General Analysis and Focus on High-Cardiovascular-Risk Subgroup— AMulticenter Study 119
OP0063 QUANTITATIVE COMPUTED TOMOGRAPHY PREDICTS 10-YEAR MORTALITY IN INTERSTITIAL LUNG DISEASE RELATED TO SYSTEMIC SCLEROSI 113
Pulmonary Arterial Hypertension Incidence in Patients With Systemic Sclerosis Treated With Bosentan for Digital Ulcers: Evidence From the SPRING-SIR Registry. 109
Long-Term Retention Rate of Tofacitinib in Rheumatoid Arthritis: An Italian Multicenter Retrospective Cohort Study 108
Multicenter observational study on the efficacy of selective Janus Kinase-1 inhibitor upatacitinib in rheumatoid arthritis 108
Prevalence and clinical relevance of digital ulcers in systemic sclerosis patients from the real-life: the experience of the SPRING Registry of the Italian Society for Rheumatology 102
First-line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING-SIR registry 98
Ixekizumab Retention Rate and Predictors of Treatment Persistence in Psoriatic Arthritis: Results of an Italian Multicenter Study 98
FRI0651 Quantitative chest ct predicts 8-years-mortality and comorbidity in systemic sclerosis 98
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 94
Elderly-onset systemic sclerosis defines a distinct clinical subset: analysis from the SPRING registry of the Italian Society for Rheumatology 90
Therapeutic Effects of Apremilast on Enthesitis and Dactylitis in Real Clinical Setting: An Italian Multicenter Study 89
Comparative effectiveness of cycling versus swapping to UL-17 inhibitors after first TNF inhibitor failure in Psoriatic Arthritis: A real- world multicenter study 64
Filgotinib Effectiveness in Rheumatoid Arthritis: Observational Analysis of a Large Multicenter Cohort 58
Menopause in systemic sclerosis: the impact on clinical presentation in a multicenter cross-sectional analysis from the National Registry of the Italian Society for Rheumatology (SPRING-SIR) 49
Gastrointestinal involvement in very early and established systemic sclerosis: insights from the SPRING-SIR national Italian registry. 46
Prevalence, distribution and associations of the scleroderma capillaroscopic patterns: new insights from the Italian SPRING-SIR registry 41
Guselkumab effectiveness in real-world settings: Observations from an Italian multicentre study 34
Does Prior Exposure Affect Retention? A Real‑World, Multicentre Assessment of IL‑17 Inhibitor Cycling in Psoriatic Arthritis 33
Exploring Disease-Specific Risk Factors for Vertebral Fractures in Systemic Sclerosis: Insights from the ScleroRER Study Group 30
Age and onset timing of Raynaud’s phenomenon and first non-Raynaud symptom as prognostic factors in systemic sclerosis: a retrospective analysis from the Italian national multicenter Systemic Sclerosis Progression INvestiGation registry of the Italian Society for Rheumatology (SPRING-SIR) 27
Comparative treatment persistence of upadacitinib vs. tofacitinib in psoriatic arthritis: a multicenter observational study from the BIRRA cohort 23
The clinical profile of systemic sclerosis without a ‘scleroderma pattern’ at nailfold capillaroscopy: results from the multicenter SPRING registry of the Italian Society of Rheumatology 20
Ixekizumab Treatment Persistence in Psoriatic Arthritis: Response to Joaquin et al 17
Drug retention of TNF versus IL-23 inhibitors in psoriatic arthritis: a multicenter real-life cohort study 10
Clinical and serological features of triple autoantibody-­ negative patients with systemic sclerosis: insights from the multicentric SPRING registry of the Italian Society for Rheumatology 9
Six months predictors of DAPSA Remission With Guselkumab in Psoriatic Arthritis in a Multicenter Real-World Study 7
Totale 17.659
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.548
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.548
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.160 31 45 86 100 47 88 42 91 150 95 243 142
2022/20231.261 157 147 89 114 127 160 51 119 177 19 51 50
2023/2024970 27 61 47 143 196 55 84 98 23 33 74 129
2024/20253.728 121 52 64 233 740 599 313 198 428 145 343 492
2025/20267.573 482 272 520 909 947 500 898 386 701 762 709 487
2026/2027328 328 0 0 0 0 0 0 0 0 0 0 0
Totale 17.659